Could Some Reports of Trastuzumab Cardiotoxicity Be a Surveillance Artifact?

J Clin Oncol. 2022 Dec 10;40(35):4158-4159. doi: 10.1200/JCO.22.01006. Epub 2022 Jul 25.

Authors

Michael S Ewer¹, Sandra M Swain¹

Affiliation

¹ Michael S. Ewer, MD, JD, PhD, and Sandra M. Swain, MD, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Georgetown Lombardi Comprehensive Cancer Center and MedStar Health, Washington, DC.

PMID: 35878103
DOI: 10.1200/JCO.22.01006

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiotoxicity* / etiology
Humans
Trastuzumab / adverse effects

Substances

Trastuzumab

Grants and funding

P30 CA051008/CA/NCI NIH HHS/United States